Scarica l'app Stockscreener
36.28
0.90%
-0.33
Dopo l'orario di chiusura:
36.28
Precedente Chiudi:
$36.61
Aprire:
$36.04
Volume 24 ore:
527.65K
Relative Volume:
0.63
Capitalizzazione di mercato:
$2.87B
Reddito:
$399.58M
Utile/perdita netta:
$-54.04M
Rapporto P/E:
-48.37
EPS:
-0.75
Flusso di cassa netto:
$40.13M
1 W Prestazione:
+3.21%
1M Prestazione:
-12.73%
6M Prestazione:
+22.69%
1 anno Prestazione:
-13.84%
Intervallo 1D:
$35.56
$36.46
Intervallo di 1 settimana:
$35.17
$37.22
Portata 52W:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
36.28 | 2.89B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Underweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Hold |
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - Finviz
Illinois Municipal Retirement Fund Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Assessing Veracyte (VCYT) Valuation After Recent Share Price Volatility - Yahoo Finance
What Veracyte (VCYT)'s UBS Rating Reaffirmation and 2026 Outlook Means For Shareholders - Yahoo Finance
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings - Bitget
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro - Finviz
Public Sector Pension Investment Board Invests $10.54 Million in Veracyte, Inc. $VCYT - MarketBeat
UBS reaffirmed buy rating on Veracyte (VCYT) after strong Q4 testing revenue - MSN
UBS Reaffirmed Buy Rating on Veracyte (VCYT) After Strong Q4 Testing Revenue - Insider Monkey
Why Veracyte Inc. (12V) stock signals breakout potential2025 Winners & Losers & Free Reliable Trade Execution Plans - mfd.ru
13 Best Innovative Stocks to Buy According to Wall Street Analysts - Insider Monkey
Is Veracyte Inc. stock gaining market shareGold Moves & Expert Curated Trade Setups - mfd.ru
Pharma News: What is the next catalyst for Veracyte IncJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Veracyte (NASDAQ:VCYT) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Is Veracyte Inc. exposed to currency risks2025 Valuation Update & Daily Profit Maximizing Trade Tips - mfd.ru
56,756 Shares in Veracyte, Inc. $VCYT Bought by Thrivent Financial for Lutherans - MarketBeat
Is Veracyte Inc.’s ROIC above industry averageTrade Volume Report & Free Community Consensus Stock Picks - mfd.ru
Can Veracyte Inc. expand into new marketsJuly 2025 Selloffs & Real-Time Buy Signal Notifications - mfd.ru
Why Veracyte Inc. stock is considered a top pickJuly 2025 Final Week & Reliable Entry Point Trade Alerts - mfd.ru
Veracyte, Inc. $VCYT Stock Holdings Increased by Allianz Asset Management GmbH - MarketBeat
Sentiment Watch: What are the future prospects of Veracyte Inc2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Is Veracyte (VCYT) Pricing Reflect Future Cash Flows After Multi Year Share Price Slide - Yahoo Finance
Federated Hermes Inc. Sells 52,039 Shares of Veracyte, Inc. $VCYT - MarketBeat
Principal Financial Group Inc. Boosts Stake in Veracyte, Inc. $VCYT - MarketBeat
How Veracyte Inc. stock responds to policy changesWeekly Risk Summary & AI Powered Buy/Sell Recommendations - mfd.ru
IQ EQ FUND MANAGEMENT IRELAND Ltd Has $4.78 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN) - The Globe and Mail
Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - BioSpace
Veracyte is Now Oversold (VCYT) - Nasdaq
Here's Why Veracyte (VCYT) is a Strong Growth Stock - Yahoo Finance
Aug Fed Impact: Can Veracyte Inc generate free cash flowJuly 2025 Earnings & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Veracyte’s Growth Story Hit A Valuation Wall - Finimize
Growth Recap: What is the Moat Score of Data Storage Corporation2025 Market Outlook & AI Driven Price Predictions - baoquankhu1.vn
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Hold" from Analysts - MarketBeat
Improved Revenues Required Before Veracyte, Inc. (NASDAQ:VCYT) Shares Find Their Feet - 富途牛牛
Targets Report: What makes Veracyte Inc. stock attractive today2025 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn
GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test - Nasdaq
Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Retain Avanos Medical Stock in Your Portfolio Now - Finviz
Can Veracyte Inc. ride the EV waveQuarterly Portfolio Report & Precise Buy Zone Identification - mfd.ru
Earnings Miss: Can Veracyte Inc expand into new marketsEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn
Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader With 17.49% Potential Upside - DirectorsTalk Interviews
Why Veracyte (VCYT) is poised to beat earnings estimates again - MSN
CLPT Gets EU MDR Certification for ClearPoint Navigation Software - Finviz
Veracyte, Inc. (VCYT) sees analyst support as Guggenheim reaffirms buy rating - MSN
Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again - Prime Publishers, Inc.
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate - Chartmill
AEGON ASSET MANAGEMENT UK Plc Has $14.06 Million Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Stronger‑Than‑Expected Revenue Outlook Might Change The Case For Investing In Veracyte (VCYT) - simplywall.st
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):